24 Hrs
Source:
الاقتصادية
Jeddah Valley boosts pharma investments with $10m fund
Tariq Company, the investment arm of the Jeddah Valley Group affiliated with King Abdulaziz University, is working to expand its investments in the pharmaceutical industry and knowledge technologies. It is focused on developing and manufacturing prescription medications. The company has launched its first line of pharmaceutical products, which include treatments for allergies, nasal sprays, and ophthalmic products, with plans to add six new products, bringing the total to 13 by the end of the year. Tariq is moving toward developing prescription drugs through partnerships with global companies and conducting clinical studies, aiming to accelerate the transfer of innovation from scientific research to the market. Additionally, it is considering establishing a clinical research center to develop prescription medications. This comes alongside Jeddah Valley’s preparations to launch a bold investment fund worth $10 million starting in 2027, to finance startups both within its ecosystem and beyond. The focus will be on sectors such as smart cities, future transportation, biotech, and industries related to food and pharmaceuticals.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)